261 related articles for article (PubMed ID: 25818762)
1. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.
Ladányi A
Pigment Cell Melanoma Res; 2015 Sep; 28(5):490-500. PubMed ID: 25818762
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of tumor-infiltrating immune cells in melanoma].
Ladányi A
Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
[TBL] [Abstract][Full Text] [Related]
3. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
4. [Function and prognostic significance of immune cells infiltrating human tumors].
Ladányi A
Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
Front Immunol; 2020; 11():2105. PubMed ID: 33013886
[TBL] [Abstract][Full Text] [Related]
6. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
11. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity in cutaneous melanoma.
Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
[TBL] [Abstract][Full Text] [Related]
13. Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma.
Neagu M; Constantin C; Tanase C
Expert Rev Mol Diagn; 2010 Oct; 10(7):897-919. PubMed ID: 20964610
[TBL] [Abstract][Full Text] [Related]
14. Ongoing adaptive immune responses in the microenvironment of melanoma metastases.
van Baren N; Coulie PG
Ann N Y Acad Sci; 2013 May; 1284():62-5. PubMed ID: 23651195
[TBL] [Abstract][Full Text] [Related]
15. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
[TBL] [Abstract][Full Text] [Related]
16. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
Schatton T; Scolyer RA; Thompson JF; Mihm MC
Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of systemic and local immune responses in cancer: time for integration.
Gutkin DW; Shurin MR
Cancer Immunol Immunother; 2014 Jan; 63(1):45-57. PubMed ID: 24100804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]